Iron-deficiency
156
7
7
106
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
14 trials with published results (9%)
Research Maturity
106 completed trials (68% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.8%
6 terminated out of 156 trials
94.6%
+8.1% vs benchmark
22%
34 trials in Phase 3/4
13%
14 of 106 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 106 completed trials
Clinical Trials (156)
Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure
Impact of Intravenous Iron Repletion On Mechanisms of Exercise InTolerance in HFpEF (IRONMET-HFpEF)
Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
Imaging Intravenous Iron
Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic Stenosis
Assessing Dietary Intake of Selected Food Components Using Short Questionnaires
Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy
An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function
Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years
Impact of Iron Supplementation Treatment on Brain Iron Concentrations
Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure
Sucrosom5al Iron Supplementation in Blood Donors
Patient Blood Management In CARdiac sUrgical patientS
Preoperative Anaemia prevaLence In surgiCal patiEnts
PEPPI Study: Identification of Women at Risk for Placental Dysfunction
Non-invasive Detection of Iron Deficiency in Obstetrics
Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas
Safety and Effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal Women
Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)
GI Effects of Iron in Healthy Volunteers